Canada - National pharmacare to make prescription drugs more accessible and affordable ♦♦♦ US - Senate panel backs giving Florida access to Canadian drugs ♦♦♦ China - Reforms to drug approvals, monitoring and pricing to improve access
András Incze

CEO & Founder

Founder & CEO of Akceso Advisors

András has led numerous successful engagements with large and smaller clients since having founded Akceso Advisors in early 2011. A former Market Pricing Director & Head Global Pricing Analysis with pharma leader Novartis, he managed pricing & reimbursement for 100 markets for the full pharma portfolio, launching successfully 15 general medicine, specialist and orphan compounds. Had global responsibility for modeling and optimisation for price, reimbursement and market access. He has been working with payers and authorities, helping shape national healthcare landscape in Argentina, Egypt, Poland & Saudi Arabia. He designed patient access programs a.o. in Asia, securing lifesaving treatment for those unable to afford it, while ensuring commercial price maintenance.

András has experience with original, generics and biosimilar products including lifecycle transitions. Prior global roles included Head Sales & Marketing Productivity and Head Capital Management. András has over 20 years experience in country, region & global roles. He is an IMD MBA, and has an MSc and Doctorate (PhD) from BME Budapest. Attended executive programs at Harvard, Stanford, IMD and INSEAD. András is co-author of 2 books on health economics and pricing, developed 4 case studies with Harvard and is an invited speaker at conferences and the IMD business school. András lives in Basel, Switzerland.